| abstract |
a pharmaceutical composition and a therapeutic method, each of which is distinguished by the fact that an antibody-drug conjugate and an immune checkpoint inhibitor are administered in combination, wherein the antibody-drug conjugate is formed by binding a drug binder represented by formula (1) (wherein a represents an antibody-binding position) to an antibody via a thioether bond; and a pharmaceutical composition and a therapeutic method, each of which is distinguished by the fact that the antibody-drug conjugate is contained and is also distinguished for being used for the treatment of a disease which can be alleviated through an immunity activating effect. antitumor. |